首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

DRUG DEVELOPMENT RESEARCH
ISSN：0272-4391

DRUG DEVELOPMENT RESEARCH

DRUG DEVELOP RES
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：较慢,6-12周
新锐分区：医学3区
年发文量：140
影响因子：4.2
JCR分区：Q1

基本信息

药物开发研究专注于与新治疗实体的发现和开发相关的研究主题。该杂志发表药物化学、药理学、生物技术和生物制药、毒理学、药物输送、制剂和药代动力学方面的原创研究文章。该杂志欢迎在所有领域的新化合物和技术的手稿，重点是人类治疗，以及全球管理，卫生保健政策，和涉及药物发现和开发过程的监管问题。除了完整的文章，药物开发研究出版重要和及时的新研究结果的简要报告，以及深入的审查文章。该杂志还定期推出专门针对特定化合物类别、新技术以及药物发现和开发的广泛方面的专题问题。
0272-4391SCIE/Scopus收录
4.2
点击查看最新影响趋势>
4
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
CHEMISTRY, MEDICINAL 药物化学
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：CHEMISTRY, MEDICINAL
SCIE
Q2
23/72
学科：PHARMACOLOGY & PHARMACY
SCIE
Q1
75/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：CHEMISTRY, MEDICINAL
SCIE
Q2
20/72
学科：PHARMACOLOGY & PHARMACY
SCIE
Q1
85/353
54
140
点击查看年发文量趋势图>
17%容易较慢,6-12周-医学-药学
2.4%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
84.29%8.73%2.34%
CiteScore：6.60
SJR：0.756
SNIP：0.805
学科类别分区排名百分位
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Drug Discovery
Q2
51 / 156

期刊高被引文献

Curcumin reduces inflammation in knee osteoarthritis rats through blocking TLR4 /MyD88/NF‐κB signal pathway
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21509
Mechanisms underlying isoliquiritigenin‐induced apoptosis and cell cycle arrest via ROS‐mediated MAPK/STAT3/NF‐κB pathways in human hepatocellular carcinoma cells
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21518
Can light‐based approaches overcome antimicrobial resistance?
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21453
Inhibiting conjugation as a tool in the fight against antibiotic resistance
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21457
Reaching toward underexplored targets in antibacterial drug design
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21465
Investigation of the antibacterial and antifungal activity of thiolated naphthoquinones
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21512
Microsponge: An emerging drug delivery strategy
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21492
Expression of Concern: Preventive effect of nerolidol on isoproterenol induced myocardial damage in Wistar rats: Evidences from biochemical and histopathological studies
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21564
Synthesis, in vivo and in silico evaluation of novel 2,3‐dihydroquinazolin‐4(1H)‐one derivatives as potential anticonvulsant agents
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21506
Synthesis, anticonvulsant screening, and molecular modeling studies of new arylalkylimidazole oxime ether derivatives
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21491
The use of aliskiren as an antifibrotic drug in experimental models: A systematic review
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21610
Dimethylaminoparthenolide reduces the incidence of dysplasia and ameliorates a wasting syndrome in HPV16‐transgenic mice
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21565
Cerebrolysin improves peripheral inflammatory pain: Sex differences in two models of acute and chronic mechanical hypersensitivity
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21528
Curcumin ameliorates experimental autoimmune encephalomyelitis in a C57BL/6 mouse model
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21540
8‐Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21531
Discovery of novel halogenated 8‐hydroxyquinoline‐based anti‐MRSA agents: In vitro and QSAR studies
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21611
Structure–activity study of fluorine or chlorine‐substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase inhibition
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21515
Discovery of a new family of heterocyclic amine linked plastoquinone analogs for antimicrobial evaluation
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21591
Drug resistance in Mycobacterium tuberculosis and targeting the l,d‐transpeptidase enzyme
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21455
Neuroprotective effects of clavulanic acid following permanent bilateral common carotid artery occlusion in rats
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21595
Mucosal gene expression changes induced by anti‐TNF treatment in inflammatory bowel disease patients
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21566
Antiviral compound screening, peptide designing, and protein network construction of influenza a virus (strain a/Puerto Rico/8/1934 H1N1)
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21475
Folic acid‐conjugated raloxifene hydrochloride carbon nanotube for targeting breast cancer cells
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21620
Effectiveness of nalbuphine, a κ‐opioid receptor agonist and μ‐opioid receptor antagonist, in the inhibition of INa, IK(M), and IK(erg) unlinked to interaction with opioid receptors
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21568
iRGD‐paclitaxel conjugate nanoparticles for targeted paclitaxel delivery
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21589
Emerging role of primary heterogeneous nucleation in pharmaceutical crystallization
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21622
Schiff base‐nickel, palladium, and platinum complexes derived from N‐cyclohexyl hydrazine carbothioamide and 3‐hydroxy‐4‐methoxybenzaldehyde: Selective antiproliferative and proapoptotic effects against colorectal carcinoma
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21559
Spontaneous mutations conferring antibiotic resistance to antitubercular drugs at a range of concentrations in Mycobacterium smegmatis
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21497
Differential regulation of intestinal and hepatic CYP3A by 1α,25‐dihydroxyvitamin D3: Effects on in vivo oral absorption and disposition of buspirone in rats
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21505
Antiviral effects of a niobium‐substituted heteropolytungstate on hepatitis B virus‐transgenic mice
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21586
Aza‐CGP37157‐lipoic hybrids designed as novel Nrf2‐inducers and antioxidants exert neuroprotection against oxidative stress and show neuroinflammation inhibitory properties
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21618
Identification of two arylimides as cholinesterase inhibitors and testing of propranolol addition on impaired rat memory
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21633
Functional mechanism of tracheal relaxation, antiasthmatic, and toxicological studies of 6‐hydroxyflavone
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21484
Cristazine, a novel dioxopiperazine alkaloid, induces apoptosis via the death receptor pathway in A431 cells
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21527
A new potential anti‐cancer beta‐carboline derivative decreases the expression levels of key proteins involved in glioma aggressiveness: A proteomic investigation
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21600
Anti‐inflammatory effects of Vicenin‐2 on dextran sulfate sodium‐induced colitis in mice
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21529
Novel histone deacetylase inhibitors bearing a 4‐piperidin‐4‐yl‐triazole scaffold as antitumor agents
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21603
Synthesis, molecular modeling studies, ADME prediction of arachidonic acid carbamate derivatives, and evaluation of their acetylcholinesterase activity
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21621
Mechanism of penehyclidine hydrochloride on a dysmenorrhea rat model
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21500
Angiotensin II‐induced micro RNA‐21 culprit for non‐small‐cell lung adenocarcinoma
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21597
Optimization of pyrrolo[3,4‐f]indole‐5,7‐dione and indole‐5,6‐dicarbonitrile derivatives as inhibitors of monoamine oxidase
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21576
In vitro and in vivo evaluation of radiolabeled methyl N‐[5‐(3′‐halobenzoyl)‐1H‐benzimidazol‐2‐yl]carbamate for cancer radiotherapy
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21604
SCN11A mRNA levels in female bipolar disorder PBMCs as tentative biomarker for distinct patient sub‐phenotypes
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21598
Design and synthesis of 2‐hydroxyl‐4‐methoxyl‐3‐(3‐methylbut‐2‐en‐1‐yl)‐6‐(4‐phenylbenzoylamino)benzoic acid derivatives as antibacterial agents based on cajaninstilbene acid scaffold hopping
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21556
Synthesis and antimicrobial evaluation of piperic acid amides and their lower homologues
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21630
Graph theoretical analysis, in silico modeling, prediction of toxicity, metabolism and synthesis of novel 2‐(methyl/phenyl)‐3‐(4‐(5‐substituted‐1,3,4‐oxadiazol‐2‐yl) phenyl) quinazolin‐4(3H)‐ones as NMDA receptor inhibitor
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21511
Modified‐release oral pellets for duodenum delivery of doxycycline hyclate
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21575
Synthesis, evaluation, molecular docking, and molecular dynamics studies of novel N‐(4‐[pyridin‐2‐yloxy]benzyl)arylamine derivatives as potential antitubercular agents
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21623
Matching pH values for antibody stabilization and crystallization suggest rationale for accelerated development of biotherapeutic drugs
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21624
Synthesis, biological evaluation, and molecular modeling of nitrile‐containing compounds: Exploring multiple activities as anti‐Alzheimer agents
来源期刊：Drug Development ResearchDOI：10.1002/ddr.21594

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

AAPS Journal封面

AAPS Journal

学科领域：医学
影响因子：3.7
中科院分区： 3区
AAPS PHARMSCITECH封面

AAPS PHARMSCITECH

学科领域：医学
影响因子：4
中科院分区： 3区
Academic Pediatrics封面

Academic Pediatrics

学科领域：医学
影响因子：2.8
中科院分区： 3区
ACTA ANAESTHESIOLOGICA SCANDINAVICA封面

ACTA ANAESTHESIOLOGICA SCANDINAVICA

学科领域：医学
影响因子：2
中科院分区： 3区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学3区
CHEMISTRY, MEDICINAL 药物化学
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
CHEMISTRY, MEDICINAL 药物化学
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
CHEMISTRY, MEDICINAL 药物化学
3区
PHARMACOLOGY & PHARMACY 药学
4区
否
否